-
Mashup Score: 3AcuraStem wins NIH, DOD grants to boost development of ALS therapies - 10 month(s) ago
AcuraStem has won nearly $7 million in funding from the NIH and the DOD for the development of therapies for ALS and related diseases.
Source: alsnewstoday.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 21ALS Society of Canada awards $200K to speed global research - 10 month(s) ago
ALS Society of Canada has awarded two scientists, one in Spain and another in the Netherlands, each a $100,000 grant to advance ALS research.
Source: alsnewstoday.comCategories: General Medicine News, Rare DiseaseTweet-
ALS Society of Canada has awarded two scientists, one in Spain and another in the Netherlands, each a $100,000 grant to advance ALS research. https://t.co/ZiD8zY00W4
-
-
Mashup Score: 5Daily IPL344 for up to 3 years seen to slow ALS progression in trial - 10 month(s) ago
Taking IPL344 daily for up to three years in a small clinical trial slowed ALS progression in patients with quickly-worsening disease.
Source: alsnewstoday.comCategories: General Medicine News, Rare DiseaseTweet-
Taking IPL344 daily for up to three years in a small clinical trial slowed ALS progression in patients with quickly-worsening disease. https://t.co/vnv3bn9xlX
-
-
Mashup Score: 3Study: Juvenile-onset ALS associated with new SPTLC2 gene mutation - 11 month(s) ago
A previously unknown mutation in the SPTLC2 gene was identified in two patients who developed juvenile-onset ALS, a study reports.
Source: alsnewstoday.comCategories: General Medicine News, Rare DiseaseTweet-
A previously unknown mutation in the SPTLC2 gene was identified in two patients who developed juvenile-onset ALS, a study reports. https://t.co/dKFJSJfXRS
-
-
Mashup Score: 3ALS Association grant to help move ORY-4001 into animal studies - 11 month(s) ago
Oryzon has been funded by the ALS Association to advance development of an HDAC6 inhibitor for treating ALS.
Source: alsnewstoday.comCategories: General Medicine News, Rare DiseaseTweet-
Lucky rodents... Oryzon has been funded by the ALS Association to advance development of an HDAC6 inhibitor for treating ALS. https://t.co/ffs2jxsTfg
-
-
Mashup Score: 1New EAP makes CNM-Au8 available to ALS patients outside trials - 1 year(s) ago
The expanded access program should provide additional clinical data supporting the safety and effectiveness of CNM-Au8 toward its approval.
Source: alsnewstoday.comCategories: Latest Headlines, Rare DiseaseTweet-
The expanded access program should provide additional clinical data supporting the safety and effectiveness of CNM-Au8 toward its approval. https://t.co/z7uvUV0epf
-
-
Mashup Score: 0
Coya plans to request regulatory approval for a Phase 2 trial testing its investigational therapy COYA 302 for the treatment of ALS
Source: alsnewstoday.comCategories: Latest Headlines, Rare DiseaseTweet-
Coya plans to request regulatory approval for a Phase 2 trial testing its investigational therapy COYA 302 for the treatment of ALS https://t.co/QiLzX9D1P5
-
-
Mashup Score: 0
While neurologists are frustrated with current treatments for ALS, they are quick to prescribe any therapy that may delay disease progression
Source: alsnewstoday.comCategories: Latest Headlines, Rare DiseaseTweet-
While neurologists are frustrated with current treatments for ALS, they are quick to prescribe any therapy that may delay disease progression https://t.co/iw7cB05ebV
-
AcuraStem has won nearly $7 million in funding from the NIH and the DOD for the development of therapies for ALS and related diseases. https://t.co/SelBZfiL2Q